Neurochemical studies on bifemelane, a new cerebral function improver: I. Effects of bifemelane on the function of neurotransmission-related enzymes and receptors in rat brain

We examined neurochemically the effects of bifemelane (BF) on muscarinic ACh (mACh-R) and /3-adrenergic receptors (β-AdR) and imipramine binding sites and the activities of acetylcholinesterase (AChE), choline acetyltransferase (CAT) and monoamine oxidase (MAO) in the P2 fractions of rat brain, ex v...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Folia Pharmacologica Japonica 1989, Vol.93(5), pp.295-304
Hauptverfasser: EGASHIRA, Toru, NAGAI, Takayuki, KIMBA, Yoshihira, TAKANO, Ritsuko, OBATA, Toshio, YAMANAKA, Yasumitsu
Format: Artikel
Sprache:jpn
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 304
container_issue 5
container_start_page 295
container_title Folia Pharmacologica Japonica
container_volume 93
creator EGASHIRA, Toru
NAGAI, Takayuki
KIMBA, Yoshihira
TAKANO, Ritsuko
OBATA, Toshio
YAMANAKA, Yasumitsu
description We examined neurochemically the effects of bifemelane (BF) on muscarinic ACh (mACh-R) and /3-adrenergic receptors (β-AdR) and imipramine binding sites and the activities of acetylcholinesterase (AChE), choline acetyltransferase (CAT) and monoamine oxidase (MAO) in the P2 fractions of rat brain, ex vivo and in vitro. Male rats were given daily injections of 10, 30 mg/kg BF, p.o., for a period of 4 weeks. The Kd and Bmax values for mACh-R in the rat forebrain by administration of 10, 30 mg/kg BF decreased significantly compared with that of the control, although the Kd and Bmax values for β-AdR and imipramine binding sites were almost identical. The Km and Vmax values of A and B-form MAO decreased in rats that had been administered 30 mg/kg BF for 4 weeks. The binding of 3H-QNB (quinuclidinyl benzilate) on mACh-R, 125I-CYP (iodocyanopindolol) on β-AdR and 3H-imipramine on imipramine binding sites decreased by 60, 20 and 70% in the presence of 1 μM BF, respectively, while the addition of 1 μM BF inhibited MAO activity by about 50%. However, CAT and AChE activities were not inhibited by BF.
doi_str_mv 10.1254/fpj.93.295
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79068047</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79068047</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2935-e54ac8880fb2f6e7c33026bbbdda293bd05368104a28fb0c13dd3cbef5c690b73</originalsourceid><addsrcrecordid>eNo9kDtPwzAURi0EKlXpwo6UiQGRYsdxYo-oKg-pggVmy3auqas8ip2A-Pc4StXleviOz736ELomeEUylj_Yw34l6CoT7AzNCc3LlFNRnqM5xoSlrBDkEi1DcBpjVmZlQckMzeJHxng2R5s3GHxndtA4o-ok9EPlICRdm2hnoYFatXCfqKSF38SAB-0jZYfW9C4yrjn47gf8Fbqwqg6wPL4L9Pm0-Vi_pNv359f14zY1maAsBZYrwznHVme2gNJQirNCa11VKgK6wowWnOBcZdxqbAitKmo0WGYKgXVJF-h28sa13wOEXjYuGKjHK7shyFLgguN8BO8m0PguBA9WHrxrlP-TBMuxNhlrk4LKWFuEb47WQTdQndBjSTFfT_k-9OoLTrnyvTM1jCoi8nzUsWlE6yk1O-UltPQffLeAgg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79068047</pqid></control><display><type>article</type><title>Neurochemical studies on bifemelane, a new cerebral function improver: I. Effects of bifemelane on the function of neurotransmission-related enzymes and receptors in rat brain</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>EGASHIRA, Toru ; NAGAI, Takayuki ; KIMBA, Yoshihira ; TAKANO, Ritsuko ; OBATA, Toshio ; YAMANAKA, Yasumitsu</creator><creatorcontrib>EGASHIRA, Toru ; NAGAI, Takayuki ; KIMBA, Yoshihira ; TAKANO, Ritsuko ; OBATA, Toshio ; YAMANAKA, Yasumitsu</creatorcontrib><description>We examined neurochemically the effects of bifemelane (BF) on muscarinic ACh (mACh-R) and /3-adrenergic receptors (β-AdR) and imipramine binding sites and the activities of acetylcholinesterase (AChE), choline acetyltransferase (CAT) and monoamine oxidase (MAO) in the P2 fractions of rat brain, ex vivo and in vitro. Male rats were given daily injections of 10, 30 mg/kg BF, p.o., for a period of 4 weeks. The Kd and Bmax values for mACh-R in the rat forebrain by administration of 10, 30 mg/kg BF decreased significantly compared with that of the control, although the Kd and Bmax values for β-AdR and imipramine binding sites were almost identical. The Km and Vmax values of A and B-form MAO decreased in rats that had been administered 30 mg/kg BF for 4 weeks. The binding of 3H-QNB (quinuclidinyl benzilate) on mACh-R, 125I-CYP (iodocyanopindolol) on β-AdR and 3H-imipramine on imipramine binding sites decreased by 60, 20 and 70% in the presence of 1 μM BF, respectively, while the addition of 1 μM BF inhibited MAO activity by about 50%. However, CAT and AChE activities were not inhibited by BF.</description><identifier>ISSN: 0015-5691</identifier><identifier>EISSN: 1347-8397</identifier><identifier>DOI: 10.1254/fpj.93.295</identifier><identifier>PMID: 2545582</identifier><language>jpn</language><publisher>Japan: The Japanese Pharmacological Society</publisher><subject>Acetylcholinesterase - metabolism ; Animals ; Antidepressive Agents - pharmacology ; Benzhydryl Compounds - pharmacology ; Brain - metabolism ; Choline O-Acetyltransferase - metabolism ; Male ; Monoamine Oxidase - metabolism ; Rats ; Rats, Inbred Strains ; Receptors, Adrenergic, beta - metabolism ; Receptors, Cholinergic - metabolism</subject><ispartof>Folia Pharmacologica Japonica, 1989, Vol.93(5), pp.295-304</ispartof><rights>The Japanese PharmacologicalSociety</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2935-e54ac8880fb2f6e7c33026bbbdda293bd05368104a28fb0c13dd3cbef5c690b73</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2545582$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>EGASHIRA, Toru</creatorcontrib><creatorcontrib>NAGAI, Takayuki</creatorcontrib><creatorcontrib>KIMBA, Yoshihira</creatorcontrib><creatorcontrib>TAKANO, Ritsuko</creatorcontrib><creatorcontrib>OBATA, Toshio</creatorcontrib><creatorcontrib>YAMANAKA, Yasumitsu</creatorcontrib><title>Neurochemical studies on bifemelane, a new cerebral function improver: I. Effects of bifemelane on the function of neurotransmission-related enzymes and receptors in rat brain</title><title>Folia Pharmacologica Japonica</title><addtitle>Nihon Yakurigaku Zasshi</addtitle><description>We examined neurochemically the effects of bifemelane (BF) on muscarinic ACh (mACh-R) and /3-adrenergic receptors (β-AdR) and imipramine binding sites and the activities of acetylcholinesterase (AChE), choline acetyltransferase (CAT) and monoamine oxidase (MAO) in the P2 fractions of rat brain, ex vivo and in vitro. Male rats were given daily injections of 10, 30 mg/kg BF, p.o., for a period of 4 weeks. The Kd and Bmax values for mACh-R in the rat forebrain by administration of 10, 30 mg/kg BF decreased significantly compared with that of the control, although the Kd and Bmax values for β-AdR and imipramine binding sites were almost identical. The Km and Vmax values of A and B-form MAO decreased in rats that had been administered 30 mg/kg BF for 4 weeks. The binding of 3H-QNB (quinuclidinyl benzilate) on mACh-R, 125I-CYP (iodocyanopindolol) on β-AdR and 3H-imipramine on imipramine binding sites decreased by 60, 20 and 70% in the presence of 1 μM BF, respectively, while the addition of 1 μM BF inhibited MAO activity by about 50%. However, CAT and AChE activities were not inhibited by BF.</description><subject>Acetylcholinesterase - metabolism</subject><subject>Animals</subject><subject>Antidepressive Agents - pharmacology</subject><subject>Benzhydryl Compounds - pharmacology</subject><subject>Brain - metabolism</subject><subject>Choline O-Acetyltransferase - metabolism</subject><subject>Male</subject><subject>Monoamine Oxidase - metabolism</subject><subject>Rats</subject><subject>Rats, Inbred Strains</subject><subject>Receptors, Adrenergic, beta - metabolism</subject><subject>Receptors, Cholinergic - metabolism</subject><issn>0015-5691</issn><issn>1347-8397</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kDtPwzAURi0EKlXpwo6UiQGRYsdxYo-oKg-pggVmy3auqas8ip2A-Pc4StXleviOz736ELomeEUylj_Yw34l6CoT7AzNCc3LlFNRnqM5xoSlrBDkEi1DcBpjVmZlQckMzeJHxng2R5s3GHxndtA4o-ok9EPlICRdm2hnoYFatXCfqKSF38SAB-0jZYfW9C4yrjn47gf8Fbqwqg6wPL4L9Pm0-Vi_pNv359f14zY1maAsBZYrwznHVme2gNJQirNCa11VKgK6wowWnOBcZdxqbAitKmo0WGYKgXVJF-h28sa13wOEXjYuGKjHK7shyFLgguN8BO8m0PguBA9WHrxrlP-TBMuxNhlrk4LKWFuEb47WQTdQndBjSTFfT_k-9OoLTrnyvTM1jCoi8nzUsWlE6yk1O-UltPQffLeAgg</recordid><startdate>1989</startdate><enddate>1989</enddate><creator>EGASHIRA, Toru</creator><creator>NAGAI, Takayuki</creator><creator>KIMBA, Yoshihira</creator><creator>TAKANO, Ritsuko</creator><creator>OBATA, Toshio</creator><creator>YAMANAKA, Yasumitsu</creator><general>The Japanese Pharmacological Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1989</creationdate><title>Neurochemical studies on bifemelane, a new cerebral function improver</title><author>EGASHIRA, Toru ; NAGAI, Takayuki ; KIMBA, Yoshihira ; TAKANO, Ritsuko ; OBATA, Toshio ; YAMANAKA, Yasumitsu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2935-e54ac8880fb2f6e7c33026bbbdda293bd05368104a28fb0c13dd3cbef5c690b73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>jpn</language><creationdate>1989</creationdate><topic>Acetylcholinesterase - metabolism</topic><topic>Animals</topic><topic>Antidepressive Agents - pharmacology</topic><topic>Benzhydryl Compounds - pharmacology</topic><topic>Brain - metabolism</topic><topic>Choline O-Acetyltransferase - metabolism</topic><topic>Male</topic><topic>Monoamine Oxidase - metabolism</topic><topic>Rats</topic><topic>Rats, Inbred Strains</topic><topic>Receptors, Adrenergic, beta - metabolism</topic><topic>Receptors, Cholinergic - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>EGASHIRA, Toru</creatorcontrib><creatorcontrib>NAGAI, Takayuki</creatorcontrib><creatorcontrib>KIMBA, Yoshihira</creatorcontrib><creatorcontrib>TAKANO, Ritsuko</creatorcontrib><creatorcontrib>OBATA, Toshio</creatorcontrib><creatorcontrib>YAMANAKA, Yasumitsu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Folia Pharmacologica Japonica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>EGASHIRA, Toru</au><au>NAGAI, Takayuki</au><au>KIMBA, Yoshihira</au><au>TAKANO, Ritsuko</au><au>OBATA, Toshio</au><au>YAMANAKA, Yasumitsu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neurochemical studies on bifemelane, a new cerebral function improver: I. Effects of bifemelane on the function of neurotransmission-related enzymes and receptors in rat brain</atitle><jtitle>Folia Pharmacologica Japonica</jtitle><addtitle>Nihon Yakurigaku Zasshi</addtitle><date>1989</date><risdate>1989</risdate><volume>93</volume><issue>5</issue><spage>295</spage><epage>304</epage><pages>295-304</pages><issn>0015-5691</issn><eissn>1347-8397</eissn><abstract>We examined neurochemically the effects of bifemelane (BF) on muscarinic ACh (mACh-R) and /3-adrenergic receptors (β-AdR) and imipramine binding sites and the activities of acetylcholinesterase (AChE), choline acetyltransferase (CAT) and monoamine oxidase (MAO) in the P2 fractions of rat brain, ex vivo and in vitro. Male rats were given daily injections of 10, 30 mg/kg BF, p.o., for a period of 4 weeks. The Kd and Bmax values for mACh-R in the rat forebrain by administration of 10, 30 mg/kg BF decreased significantly compared with that of the control, although the Kd and Bmax values for β-AdR and imipramine binding sites were almost identical. The Km and Vmax values of A and B-form MAO decreased in rats that had been administered 30 mg/kg BF for 4 weeks. The binding of 3H-QNB (quinuclidinyl benzilate) on mACh-R, 125I-CYP (iodocyanopindolol) on β-AdR and 3H-imipramine on imipramine binding sites decreased by 60, 20 and 70% in the presence of 1 μM BF, respectively, while the addition of 1 μM BF inhibited MAO activity by about 50%. However, CAT and AChE activities were not inhibited by BF.</abstract><cop>Japan</cop><pub>The Japanese Pharmacological Society</pub><pmid>2545582</pmid><doi>10.1254/fpj.93.295</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0015-5691
ispartof Folia Pharmacologica Japonica, 1989, Vol.93(5), pp.295-304
issn 0015-5691
1347-8397
language jpn
recordid cdi_proquest_miscellaneous_79068047
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Acetylcholinesterase - metabolism
Animals
Antidepressive Agents - pharmacology
Benzhydryl Compounds - pharmacology
Brain - metabolism
Choline O-Acetyltransferase - metabolism
Male
Monoamine Oxidase - metabolism
Rats
Rats, Inbred Strains
Receptors, Adrenergic, beta - metabolism
Receptors, Cholinergic - metabolism
title Neurochemical studies on bifemelane, a new cerebral function improver: I. Effects of bifemelane on the function of neurotransmission-related enzymes and receptors in rat brain
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T05%3A34%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neurochemical%20studies%20on%20bifemelane,%20a%20new%20cerebral%20function%20improver:%20I.%20Effects%20of%20bifemelane%20on%20the%20function%20of%20neurotransmission-related%20enzymes%20and%20receptors%20in%20rat%20brain&rft.jtitle=Folia%20Pharmacologica%20Japonica&rft.au=EGASHIRA,%20Toru&rft.date=1989&rft.volume=93&rft.issue=5&rft.spage=295&rft.epage=304&rft.pages=295-304&rft.issn=0015-5691&rft.eissn=1347-8397&rft_id=info:doi/10.1254/fpj.93.295&rft_dat=%3Cproquest_cross%3E79068047%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79068047&rft_id=info:pmid/2545582&rfr_iscdi=true